Sacubitril/valsartan in real‐life European patients with heart failure and reduced ejection fraction: a systematic review and meta‐analysis-Reference-Cited by-同舟云学术

Sacubitril/valsartan in real‐life European patients with heart failure and reduced ejection fraction: a systematic review and meta‐analysis

Published:2021-08-02 Issue:5 Volume:8 Page:3547-3556
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Giovinazzo Stefano¹,Carmisciano Luca²,Toma Matteo¹,Benenati Stefano¹³,Tomasoni Daniela⁴,Sormani Maria Pia²,Porto Italo¹³,Canepa Marco¹³,Senni Michele⁵,Metra Marco⁴,Ameri Pietro¹³^ORCID

Affiliation:

1. Cardiovascular Disease Unit, IRCCS Ospedale Policlinico San Martino IRCCS Italian Cardiology Network Genoa Italy

2. Department of Health Sciences, Section of Biostatistics University of Genova Genoa Italy

3. Department of Internal Medicine University of Genova Genoa Italy

4. Cardiology Unit, ASST Spedali Civili and Department of Medical and Surgical Specialties, Radiological Sciences and Public Health University of Brescia Brescia Italy

5. Cardiology Division, Cardiovascular Department Ospedale Papa Giovanni XXIII Bergamo Italy

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.13547

Reference45 articles.

1. Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

2. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

3. What proportion of patients with chronic heart failure are eligible for sacubitril-valsartan?

4. Sacubitril/valsartan eligibility and outcomes in the ESC‐EORP‐HFA Heart Failure Long‐Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM‐HF trial, ESC guidelines, and real world

5. Association of Change in N-Terminal Pro–B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection Fraction

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Novel Molecular Imprinting Polymerbased Optical Fiber Sensor for Valsartan;2024 14th International Symposium on Communication Systems, Networks and Digital Signal Processing (CSNDSP);2024-07-17

2. Trajectories of Sacubitril/Valsartan Adherence Among Medicare Beneficiaries With Heart Failure;JACC: Advances;2024-07

3. OPTImal PHARMacological therapy for patients with heart failure: Rationale and design of the OPTIPHARM‐HF registry;European Journal of Heart Failure;2024-06-23

4. Real-life effectiveness of sacubitril/valsartan in older Belgians with heart failure, reduced ejection fraction and most severe symptoms;Scientific Reports;2024-06-12

5. 2024 update in heart failure;ESC Heart Failure;2024-05-28